Interface Biologics

From WikiCover

Jump to: navigation, search

Interface Biologics Inc. (IBI) is a privately held biomaterials company located in Toronto, Canada. The company develops and markets cutting edge polymer technologies that are programmed at the nano level for the combination medical device marketplace.

On August 20, 2007, Interface Biologics announced the addition of Dr. Nicolas Chronos to its advisory board.

Website: http://www.interfacebiologics.com/